Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

Freya Biosciences: pioneering the development of microbial immunotherapies for women’s health

Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.

At the 8th Annual Microbiome Movement Drug Development Europe in Barcelona, Spain, MicrobiomePost conducted an exclusive interview with Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, to discuss the latest advancements in microbial immunotherapies for women’s health.

Most recent

HCPs Area

Industry

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy